Principia Biopharma Inc (PRNB) Annual Balance Sheets

Annual · GAAP · USD millions
Access PRNB quarterly Balance Sheets →
Examining balance sheet movements between Principia Biopharma Inc and reveals how Dec 31 2019 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2019)
(Dec 31 2018)
Assets
Cash & cash equivalent39.54
Marketable Securities, Current SH276.04
Cash & Short-term Investments315.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.17
Total Current Assets319.75
Equipment/Property/Plant Net9.69
Long-term investments52.26
Other Assets, Noncurrent1.05
Total Assets382.74
Liabilities
Accounts Payable, Current AC1.85
Accrued Liabilities, Current7.32
Deferred Rent Credit, Current DE1.18
Total Current Liabilities16.14
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE7.62
Accrued Research And Development Liability Current5.79
Total Liabilities23.76
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock544.71
Retained Earnings / Accumulated Deficit-185.74
Other Equity0.01
Common Stockholder's Equity358.98
Total Stockholder's Equity358.98
Liabilities & Stockholder's Equity382.74
4 historic quarters locked

Sign in to unlock the full Principia Biopharma Inc balance sheet history.

About PRNB Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.